AIM announces Paul Goepfert, MD, as the principal investigator for the planned clinical study of Ampligen and FluMist as a vaccine for avian influenza Seeking Alpha / - 4 hours from now
The Now Corporation (OTC: NWPN) Announces Launch of New Website: GreenRainEnergy.com Seeking Alpha / - 4 hours from now
AMD Unveils Next-Generation AMD RDNA™ 4 Architecture with the Launch of AMD Radeon™ RX 9000 Series Graphics Cards Seeking Alpha / - 4 hours from now
Zevra Launches New Disease State Awareness Campaign, ‘Learn NPC, Read Between the Signs,’ to Drive Early Recognition and Treatment of Niemann-Pick Disease Type C Seeking Alpha / - 3 hours from now
Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results Seeking Alpha / - 2 hours from now
Comments